Liu Mingxiang, Wu Chaoqun, Wu Chaofan, Zhou Zulong, Fang Run, Liu Chenfeng, Ning Rende
Department of Orthopedics, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), School of Life Science, Anhui Medical University, Hefei, Anhui, China.
Front Immunol. 2025 Mar 25;16:1545284. doi: 10.3389/fimmu.2025.1545284. eCollection 2025.
Osteoarthritis (OA) is a chronic disease primarily characterized by degenerative changes in articular cartilage and synovitis, for which there are currently no targeted or curative therapies available in clinical practice. In recent years, the in-depth analysis of OA using single-cell sequencing and immunomics technologies has revealed the presence of multiple immune cell subsets, as well as different differentiation states within the same subset, in OA. Through immune-immune and immune-joint tissue interactions, these cells collectively promote or inhibit the progression of arthritis. This complex immune network, where "friends and foes coexist," has made targeted therapeutic strategies aimed at directly eliminating immune cells challenging, highlighting the urgent need for a detailed review of the composition, distribution, functional heterogeneity, therapeutic potential, and potential risks of immune subsets within the joint. Additionally, the similarities and differences between OA and rheumatoid arthritis (RA) in terms of diagnosis and immunotherapy need to be precisely understood, in order to draw lessons from or reject RA-based immunotherapies. To this end, this review summarizes the major triggers of inflammation in OA, the differentiation characteristics of key immune cell subsets, and compares the similarities and differences between OA and RA in diagnosis and treatment. It also outlines the current immunomodulatory strategies for OA and their limitations. Furthermore, we provide a detailed and focused discussion on immune cells that act as "friends or foes" in arthritis, covering the M1/M2 polarization of macrophages, functional heterogeneity of neutrophils, unique roles of dendritic cells at different maturation states, the balance between pro-inflammatory T cells and regulatory T cells (Tregs), and the diverse functions of B cells, plasma cells, and regulatory B cells (Bregs) in OA. By interpreting the roles of these immune cells, this review clarifies the dynamic changes and interactions of immune cells in OA joints, providing a theoretical foundation for more precise targeted interventions in future clinical practice.
骨关节炎(OA)是一种主要以关节软骨退变和滑膜炎为特征的慢性疾病,目前临床实践中尚无针对性或治愈性疗法。近年来,利用单细胞测序和免疫组学技术对OA进行的深入分析揭示了OA中存在多种免疫细胞亚群,以及同一亚群内不同的分化状态。通过免疫-免疫和免疫-关节组织相互作用,这些细胞共同促进或抑制关节炎的进展。这个“敌友共存”的复杂免疫网络使得旨在直接消除免疫细胞的靶向治疗策略具有挑战性,凸显了迫切需要详细综述关节内免疫亚群的组成、分布、功能异质性、治疗潜力和潜在风险。此外,需要准确了解OA与类风湿关节炎(RA)在诊断和免疫治疗方面的异同,以便借鉴或摒弃基于RA的免疫疗法。为此,本综述总结了OA炎症的主要触发因素、关键免疫细胞亚群的分化特征,并比较了OA与RA在诊断和治疗方面的异同。还概述了目前OA的免疫调节策略及其局限性。此外,我们对在关节炎中扮演“朋友或敌人”角色的免疫细胞进行了详细而有针对性的讨论,涵盖巨噬细胞的M1/M2极化、中性粒细胞的功能异质性、不同成熟状态下树突状细胞的独特作用、促炎T细胞与调节性T细胞(Tregs)之间的平衡,以及B细胞、浆细胞和调节性B细胞(Bregs)在OA中的多种功能。通过解读这些免疫细胞的作用,本综述阐明了OA关节中免疫细胞的动态变化和相互作用,为未来临床实践中更精确的靶向干预提供了理论基础。